
The Kerala Sastra Sahitya Parishad backed the Kerala Health Department's decision to provide a low-cost generic version of Risdiplam.
Risdiplam is used to treat Spinal Muscular Atrophy, a rare genetic disorder causing progressive muscle weakness.
KSSP leaders stated that ensuring life-saving treatment accessibility is a vital humanitarian responsibility for patients.